Blood cancers

Podcast: Long-term data and patient priorities inform R/R CLL management

Sponsored by Janssen-Cilag Pty Ltd

In this podcast Professor Susan O’Brien from Irvine, USA, explains the importance she places on long-term safety and efficacy data when making treatment decisions in R/R CLL. She also describes how she talks through treatment options with patients to determine the management approach best suited to their individual needs. Professor O’Brien is Associate Director for ...

Already a member?

Login to keep reading.

© 2021 the limbic